On Oct 10, 2023, Myriad Genetics Inc Agreed On New Long-Term Agreement With UnitedHealthCare; Contract Amendment Is Effective January 1, 2024 And Runs Through December 31, 2027
Portfolio Pulse from Benzinga Newsdesk
Myriad Genetics Inc has entered into a new long-term agreement with UnitedHealthCare. The contract amendment will be effective from January 1, 2024, and will run through December 31, 2027.
October 11, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The new long-term agreement with UnitedHealthCare could provide Myriad Genetics with a stable revenue stream for the next few years.
Long-term agreements often provide companies with a predictable and stable revenue stream. This agreement with UnitedHealthCare could therefore be beneficial for Myriad Genetics' financial stability and growth over the next few years.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
The long-term agreement with Myriad Genetics could help UnitedHealthCare secure reliable genetic testing services for the next few years.
Long-term agreements can help companies secure reliable services for an extended period. This agreement with Myriad Genetics could therefore be beneficial for UnitedHealthCare's ability to provide consistent and reliable genetic testing services to its customers over the next few years.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100